Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-058861
Filing Date
2012-12-20
Accepted
2012-12-20 17:19:10
Documents
1
Period of Report
2012-12-18

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c30805_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c30805_4x0.xml 4 3783
  Complete submission text file 0001209191-12-058861.txt   5338
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Issuer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O BIOGEN IDEC INC. 133 BOSTON POST ROAD WESTON MA 02493
Business Address
DiPietro Kenneth (Reporting) CIK: 0001540188 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52089 | Film No.: 121278062